Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hwan Geun Choi

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Expert Opinion on Therapeutic Patents|November 7, 2012
Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)Xianming Deng, Hwan Geun Choi, Sara J Buhrlage, et al.
Advances in Neurobiology|March 30, 2017
Small-Molecule Inhibitors of LRRK2John M Hatcher, Hwan Geun Choi, Dario R Alessi, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2012
Characterization of TAE684 as a potent LRRK2 kinase inhibitorJinwei Zhang, Xianming Deng, Hwan Geun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
Development of 'DFG-out' inhibitors of gatekeeper mutant kinasesHwan Geun Choi, Jianming Zhang, Ellen Weisberg, et al.
Journal of Translational Autoimmunity|January 19, 2023
FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitisSoochan Kim, Eunhwa Ko, Hwan Geun Choi, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJohn M Hatcher, Jinwei Zhang, Hwan Geun Choi, et al.
Oncotarget|September 9, 2017
Structural basis of mutant-selectivity and drug-resistance related to CO-1686Xiao-E Yan, Su-Jie Zhu, Ling Liang, et al.
Experimental & Molecular Medicine|August 2, 2022
Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stressDebra Dorotea, Songling Jiang, Eun Seon Pak, et al.
The Journal of Biological Chemistry|April 19, 2012
Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cellsEduardo Pauls, Natalia Shpiro, Mark Peggie, et al.
Biomolecules & Therapeutics|July 22, 2020
KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in MiceDebra Dorotea, Seungyeon Lee, Sun Joo Lee, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Expert Opinion on Therapeutic Patents|November 7, 2012
Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011)Xianming Deng, Hwan Geun Choi, Sara J Buhrlage, et al.
Advances in Neurobiology|March 30, 2017
Small-Molecule Inhibitors of LRRK2John M Hatcher, Hwan Geun Choi, Dario R Alessi, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2012
Characterization of TAE684 as a potent LRRK2 kinase inhibitorJinwei Zhang, Xianming Deng, Hwan Geun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
Development of 'DFG-out' inhibitors of gatekeeper mutant kinasesHwan Geun Choi, Jianming Zhang, Ellen Weisberg, et al.
Journal of Translational Autoimmunity|January 19, 2023
FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitisSoochan Kim, Eunhwa Ko, Hwan Geun Choi, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJohn M Hatcher, Jinwei Zhang, Hwan Geun Choi, et al.
Oncotarget|September 9, 2017
Structural basis of mutant-selectivity and drug-resistance related to CO-1686Xiao-E Yan, Su-Jie Zhu, Ling Liang, et al.
Experimental & Molecular Medicine|August 2, 2022
Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stressDebra Dorotea, Songling Jiang, Eun Seon Pak, et al.
The Journal of Biological Chemistry|April 19, 2012
Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cellsEduardo Pauls, Natalia Shpiro, Mark Peggie, et al.
Biomolecules & Therapeutics|July 22, 2020
KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in MiceDebra Dorotea, Seungyeon Lee, Sun Joo Lee, et al.
Pageof 6